VALPROIC ACID
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
70752-202 -
Package NDC
70752-202-12 -
Application number
ANDA090517 -
SPL ID
a8e717fe-e79e-46f6-90da-8b8cfe78fae7 -
SPL set ID
531c0fc7-5e80-49a5-a9d1-0916ec45d52c -
UNII
614OI1Z5WI -
RxCUI
1099687
What the source publishes
- Labeler
- QUAGEN PHARMACEUTICALS LLC
- Active ingredients
- VALPROIC ACID
- Form
- SOLUTION
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "VALPROIC ACID",
"splId": "a8e717fe-e79e-46f6-90da-8b8cfe78fae7",
"labels": [
{
"setId": "531c0fc7-5e80-49a5-a9d1-0916ec45d52c",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=531c0fc7-5e80-49a5-a9d1-0916ec45d52c",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=531c0fc7-5e80-49a5-a9d1-0916ec45d52c"
}
],
"routes": [
"ORAL"
],
"labeler": "QUAGEN PHARMACEUTICALS LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "12 BOTTLE in 1 CASE (70752-202-12) / 473 mL in 1 BOTTLE",
"package_ndc": "70752-202-12",
"identifierStatus": "well-formed",
"marketing_start_date": "20240415"
}
],
"productId": "70752-202_a8e717fe-e79e-46f6-90da-8b8cfe78fae7",
"useDomain": "unknown",
"dosageForm": "SOLUTION",
"productNdc": "70752-202",
"deaSchedule": null,
"genericName": "VALPROIC ACID",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "VALPROIC ACID",
"strength": "250 mg/5mL"
}
],
"applicationNumber": "ANDA090517",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20240415",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175753",
"N0000008486",
"N0000175751"
],
"unii": [
"614OI1Z5WI"
],
"rxcui": [
"1099687"
],
"spl_set_id": [
"531c0fc7-5e80-49a5-a9d1-0916ec45d52c"
],
"pharm_class_pe": [
"Decreased Central Nervous System Disorganized Electrical Activity [PE]"
],
"pharm_class_epc": [
"Anti-epileptic Agent [EPC]",
"Mood Stabilizer [EPC]"
],
"manufacturer_name": [
"QUAGEN PHARMACEUTICALS LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:70752-202_a8e717fe-e79e-46f6-90da-8b8cfe78fae7"